Ram Waisbourd

Insider Reports History

Reporting-owner location: San Francisco, CA
Latest reporting-owner signature: /s/ Ryan A. Murr, as attorney-in-fact for Ram Waisbourd
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Ram Waisbourd

Form 4 holding Chief Operating Officer and Chief Business Officer

89bio, Inc.

Security class: Common Stock
Shares / value: 8,750
Estimated value: $100,888
Report date: 17 Feb 2022
Price: $11.53
Ownership: Direct

Form 4 holding Chief Operating Officer and Chief Business Officer

89bio, Inc.

Security class: Stock Option (Right to Buy)
Shares / value: 25,000
Estimated value
Report date: 17 Feb 2022
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Insider Reports Filed by Ram Waisbourd

4 ETNB

89bio, Inc.

Report period: 17 Feb 2022
Transactions: 3
Transaction value: $0
Accepted by SEC: 22 Feb 2022, 16:13
Role: Chief Operating Officer and Chief Business Officer
Next action: Open filing details

4 ETNB

89bio, Inc.

Report period: 01 Feb 2022
Transactions: 5
Transaction value: -$26,390
Accepted by SEC: 03 Feb 2022, 15:30
Role: Chief Operating Officer and Chief Business Officer
Next action: Open filing details

4 ETNB

89bio, Inc.

Report period: 16 Dec 2021
Transactions: 3
Transaction value: -$66,850
Accepted by SEC: 20 Dec 2021, 15:30
Role: Chief Operating Officer and Chief Business Officer
Next action: Open filing details

4 ETNB

89bio, Inc.

Report period: 16 Nov 2021
Transactions: 3
Transaction value: -$101,920
Accepted by SEC: 18 Nov 2021, 17:37
Role: Chief Operating Officer and Chief Business Officer
Next action: Open filing details

4 ETNB

89bio, Inc.

Report period: 18 Oct 2021
Transactions: 3
Transaction value: -$108,920
Accepted by SEC: 20 Oct 2021, 16:30
Role: Chief Operating Officer and Chief Business Officer
Next action: Open filing details

4 ETNB

89bio, Inc.

Report period: 16 Sep 2021
Transactions: 3
Transaction value: -$122,710
Accepted by SEC: 20 Sep 2021, 16:32
Role: Chief Operating Officer and Chief Business Officer
Next action: Open filing details

4 ETNB

89bio, Inc.

Report period: 16 Aug 2021
Transactions: 3
Transaction value: -$114,450
Accepted by SEC: 18 Aug 2021, 16:10
Role: Chief Operating Officer and Chief Business Officer
Next action: Open filing details

4 ETNB

89bio, Inc.

Report period: 16 Jul 2021
Transactions: 3
Transaction value: -$104,090
Accepted by SEC: 19 Jul 2021, 16:05
Role: Chief Operating Officer and Chief Business Officer
Next action: Open filing details

4 ETNB

89bio, Inc.

Report period: 16 Jun 2021
Transactions: 3
Transaction value: -$124,180
Accepted by SEC: 21 Jun 2021, 16:30
Role: Chief Operating Officer and Chief Business Officer
Next action: Open filing details

4 ETNB

89bio, Inc.

Report period: 17 May 2021
Transactions: 3
Transaction value: -$137,760
Accepted by SEC: 19 May 2021, 16:30
Role: Chief Operating Officer and Chief Business Officer
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .